Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Gains from Investment Securities: 2012-2025

Historic Gains from Investment Securities for Phibro Animal Health (PAHC) over the last 13 years, with Jun 2025 value amounting to $4.5 million.

  • Phibro Animal Health's Gains from Investment Securities rose 432.79% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 19.25%. This contributed to the annual value of $4.5 million for FY2025, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2025, Phibro Animal Health's Gains from Investment Securities is $4.5 million, which was down 0.00% from $4.5 million recorded in FY2024.
  • In the past 5 years, Phibro Animal Health's Gains from Investment Securities ranged from a high of $5.1 million in FY2022 and a low of $4.5 million during FY2024.
  • Its 3-year average for Gains from Investment Securities is $4.7 million, with a median of $4.5 million in 2025.
  • Data for Phibro Animal Health's Gains from Investment Securities shows a maximum YoY declined of 11.81% (in 2024) over the last 5 years.
  • Over the past 4 years, Phibro Animal Health's Gains from Investment Securities (Yearly) stood at $5.1 million in 2022, then remained steady at $5.1 million in 2023, then fell by 11.81% to $4.5 million in 2024, then remained steady at $4.5 million in 2025.